The Fungal Srebp Pathway As a Target for Anti-fungal Agents

Inhibition of Srel activity and/or expression has great potential for antifungal therapeutics. Disclosed herein are novel methods and compositions useful for the identification of novel inhibitors of Srel activity and/or function and the treatment of fungal infections.

Patents:
WO 2,011,031,471

Inventor(s): ESPENSHADE PETER J [US]; BIEN CLARA M [US]

Type of Offer: Licensing



Next Patent »
« More Medical Patents

Share on      


CrowdSell Your Patent